Abstract
The selective D2-dopamine receptor antagonist raclopride and its pharmacologically inactive (R)-enantiomer FLB472 were labelled with 11C and used in a study with positron emission tomography to examine the stereoselectivity of 11C-raclopride binding to central D2-dopamine receptors in three healthy men. After the injection of 11C-raclopride, there was a high accumulation of radioactivity in the dopamine-rich basal ganglia, whereas after the injection of 11C-FLB472 there was no such accumulation of radioactivity. Thus, the binding of 11C-raclopride is stereoselective. Distribution ratios [radioactivity in a brain region/“free” (not protein-bound) radioactivity in plasma] were calculated for the two enantiomers to study regional differences in the accumulation of radioactivity. The distribution ratios in white matter were similar for the two enantiomers. In the putamen, a three to four-fold higher distribution ratio was found for 11C-raclopride than for 11C-FLB472, reflecting the presence of specific binding of 11C-raclopride binding to D2-dopamine receptors in the basal ganglia. In the temporal and frontal cortices the distribution ratios were, however, only a few per cent higher for 11C-raclopride than for 11C-FLB472, indicating that if D2-dopamine receptors are present in the human neocortex, then their density is indeed very low.
Similar content being viewed by others
References
Bannon MJ, Roth RH (1983) Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 35:53–68
Bergström M (1982) Performance evaluation and improvements of quantitation accuracy in transmission and positron emission computer assisted tomography. Thesis. Karolinska Institutet, Stockholm
Bergström M, Boethius J, Eriksson L, Greitz T, Ribbe T, Widen L (1981) Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 5:136–141
Bischoff S (1986) Mesohippocampal dopamine system. Characterization, functional and clinical implications. In: Isaacsson RL, Pribram KH (eds) The hippocampus, vol 3. Plenum Press, pp 1–30
Björklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Björklund O, Hökfelt T (eds) Handbook of chemical neuroanatomy. Classical transmitters in the CNS, vol 2, part I. Elsevier, Amsterdam, pp 55–122
Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140–144
Craig DP (1976) Discriminating interactions between chiral molecules. Top Curr Chem 63:1–48
Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481–483
Ehrin E, Gawell L, Högberg T, dePaulis T, Ström P (1987) Synthesis of (methoxy-3H) — and (methoxy-11C)-labelled raclopride — specific dopamine-D2 receptor ligands. J Labelled Comp Radiopharm 24:931–939
Farde L, Ehrin E, Eriksson L, Greitz TY, Hall H, Hedström CG, Litton JE, Sedvall G (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82:3863–3867
Farde L, Hall H, Ehrin E, Sedvall G (1986) Quantitative analysis of dopamine-D2 receptor binding in the living human brain by positron emission tomography. Science 231:258–261
Farde L, Halldin C, Stone-Elander S, Sedvall G (1987a) PET analysis of human dopamine receptor subtypes 11C-SCH 23390 and 11C-raclopride. Psychopharmacology 92:278–284
Farde L, Wiesel F-A, Hall H, Halldin C, Stone-Elander S, Sedvall G (1987b) No D2 Receptor Increase in PET Study of Schizophrenia. Arch Gen Psychiatry 44:671–672
Farde L, Wiesel F-A, Halldin C, Sedvall G (1988a) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry (in press)
Farde L, Wiesel F-A, Jansson P, Uppfeldt G, Wahlen A, Sedvall G (1988b) An open label trial of raclopride in acute schizophrenia — confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology 94:1–7
Giacomini J, Nelson W, Theodore L, Wong F, Rood D, Giacomini K (1985) The pharmacokinetics and pharmacodynamics of d- and dl-verapamil in rabbits. J Cardiovasc Pharmacol 7:469–475
Glowinski J, Tassin GP, Thierry AM (1984) The mesocortico-prefrontal dopaminergic neurons. Trends Neurosci 18:415–418
Hall H, Wedel I (1986) Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. Acta Pharmacol Toxicol 58:368–373
Hall H, Farde L, Sedvall G (1987) Human dopamine receptor subtypes — in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride. J Neural Transm (in press)
James A, Roos M (1975) Minuit. Comput Physics Commun 10:343–367
De Keyser J, De Backer J-P, Eginger G, Vauquelin G (1985) Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain. J Neurol Sci 71:119–127
Köhler C, Hall H, Ögren S-O, Gawell L (1985) Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D2 receptors in the rat brain. Biochem Pharmacol 34:2251–2259
Köhler C, Radesäter AC (1986) Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug (3H) raclopride. Neurosci Lett 66:85–90
Litton J, Bergström L, Eriksson L, Bohm C, Blomqvist G, Kesselberg M (1984) Performance study of the PC-384 positron camera system for emission tomography of the brain. J Comput Assist Tomogr 8:74–87
Martes M-P, Bouthenet M-L, Sales N, Sokoloff P, Schwartz J-C (1985) Widespread distribution of brain dopamine receptors evidenced with (125I)iodosulpride, a highly selective ligand. Science 228:752–754
Mazziotta JC, Phelps ME, Plummer D, Kuhl D (1981) Quantitation in positron emission computed tomography: 5. Physical — anatomical effects. J Comput Assist Tomogr 5(5):734–743
Olanoff L, Walle T, Walle K, Cowart D, Gaffney T (1984) Stereoselective clearance and distribution of intravenous propranolol. Clin Pharmacol Ther 35:755–761
Pennkopf E (1963) Atlas der topographischen und angewandten Anatomie des Menschen. Erster Band: Kopf und Hals. 106. Urban und Schwarzenberg, Munich
Sedvall G, Farde L, Persson A, Wiesel F-A (1986) Imaging of neurotransmitter receptors in the living human brain. Arch Gen Psychiatry 43:995–1005
Sedvall G, Ehrin E, Farde L (1987) Stereoselective binding of 11C-labelled piquindone (Ro22–1319) to dopamine-D2 receptors in the living human brain. Hum Psychopharmacol 2:23–30
Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717–719
Smith DF (1984) Stereopsychopharmacology: Past, present and future. Biol Psychiatry 8:327–350
Snyder SH, Pasternak GW, Pert CB (1975) Opiate receptor mechanisms. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, Vol 5. Plenum Press, New York, pp 329–360
Thijssen H, Baars L, Drittij-Reijnders J (1985) Stereoselective aspects in the pharmacokinetics and pharmacodynamics of acenocumarol and its amino and acetamide derivatives in the rat. Drug Metab Dispos 13:593–597
Thierry A-M, Tassin J-P, Glowinski J (1984) Biochemical and electrophysiological studies of the mesocortical dopamine system. In: Monoamine innervation of cerebral cortex. Liss, New York, pp 233–261
Wagner HN, Burns HD, Dannals RF, Wong DF, L»ngström B, Duelfer T, Frost JJ, Raert HT, Links JM, Rosenblom SB, Lukas SE, Kramer AV, Kuhar MJ (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 221:1264–1266
Ögren S-O, Hall H, Köhler C, Magnussen O, Sjöstrand S-O (1986) The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology 90:287–294
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farde, L., Pauli, S., Hall, H. et al. Stereoselective binding of 11C-raclopride in living human brain — a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacology 94, 471–478 (1988). https://doi.org/10.1007/BF00212840
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00212840